Our News
Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM’s financial support
Our News
CQDM, IVADO, and two Quebec-based companies join forces to accelerate the diagnosis of pancreatic neuroendocrine tumors using artificial intelligence
Events
Sweet pharma day
Events
Connect-BIO: Reinventing Preclinical Research – Approaches to Reduce Animal Use
Our News
Newly hired, Koffi Loch, Chief accountant
Our News
Our first event Connect-Café
Our News
CQDM and Brain Canada invest over $5.4M to drive neuroscience innovation in Canada
News from the industry
Congratulations to Variational AI on their collaboration with Merck!
News from the industry